Novo CEO pressed by Senate to cut costs of being overweight, diabetes medicine CEO Lars Fruergaard Jørgensen instructed lawmakers the company would think about new talks with insurers in regards to the listing costs of Wegovy and copyright should they pledge to help keep the medicines on their formularies. Before https://aya-healthcare-address97840.59bloggers.com/31055932/considerations-to-know-about-healthcare-news